WKN DE: A422F7 / ISIN: US2825641036

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

Eikon Therapeutics Times and Sales (NAS)

Zeit	Kurs	Umsatz (Stk)
18:45:52	10,240	29
18:45:03	10,245	100
18:44:58	10,200	26
18:44:58	10,200	30
18:44:58	10,210	10
18:44:58	10,210	10
18:44:58	10,210	24
18:43:12	10,255	4
18:43:08	10,200	70
18:42:49	10,270	100
18:42:49	10,230	92
18:42:47	10,230	8
18:42:40	10,245	100
18:42:38	10,270	3
18:42:36	10,270	27
18:42:34	10,290	6
18:42:34	10,290	6
18:42:32	10,290	147
18:42:32	10,310	2
18:42:32	10,290	3
18:42:32	10,310	27
18:42:32	10,310	21
18:42:32	10,300	100
18:42:32	10,310	73
18:42:32	10,270	170
18:42:32	10,280	20
18:42:32	10,280	10
18:42:29	10,280	300
18:42:28	10,310	100
18:42:28	10,330	1
18:42:28	10,280	100
18:42:26	10,290	77
18:42:26	10,290	23
18:42:26	10,290	11
18:42:26	10,290	8

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu Eikon Therapeutics Inc Registered Shs

Weitere Meldungen

14:40		Astera Labs vs. Arm: Which Technology Stock Is a Better Buy in 2026?
14:40		Executive Sells Nearly $300,000 Worth of Avery Dennison Stock
14:36		Think Maxing Out a 401(k) Is Always Smart? This Might Make You Change Your Mind.
14:35		Arthur Hayes Backs Bitcoin, Says US Will Have to 'Print Trillions' to Save the Yen
14:29		Airbnb has added thousands of new hotel listings. Will that damage the brand’s identity?
14:28		Rocket Lab Reports Q2 Revenue Beat, Record Backlog — Stock Falls Anyway
14:27		This Best Buy Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
14:27		Sea Bets Shopee Can Hit $1 Billion in Profit As E-Commerce Growth Roars
14:24		A $1.3 Billion Mortgage Deal Went Wrong. Now UWM Wants $500 Million From Two Harbors.
14:23		Better (BETR) Q2 2026 Earnings Call Transcript
14:20		Volatility tumbles as markets shrug off Middle East risks
14:18		Is Redwire Stock a Buy After Its Bold Defense Pivot?
14:17		AST SpaceMobile Stock Reverses Higher Despite Missing on Both Top and Bottom Lines
14:16		Warsh’s changes to forward guidance were tried by one central bank — and here’s what happened
14:15		Scott Bessent Tells Robert Reich 'McDonald's Problem Is Called Burger King, Professor' Amid Clash Over the 'K-Shaped' Economy: 'No Wonder Bill Clinton...'
14:15		Better Buy in August: Celsius Down 42% This Year or a 50/50 Split of Coca-Cola and Pepsi?
14:13		Micron Stock Is Down 28%, and Here Is What Investors Need to Know
14:11		These Analysts Boost Their Forecasts On Riot Platforms After Q2 Results
14:09		AI agent hacks gym to get its user a spot in pilates class
14:05		Jamie Dimon Has a Warning for Investors: Inflation May Not Be Coming Down
14:05		Twilio, Transocean, Blackstone And More On CNBC’s ‘Final Trades’
14:04		This AppLovin Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
14:04		OppFi Posts Downbeat Q2 Earnings, Joins Upwork, Rocket Lab And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
14:02		Singapore Land posts 90% higher net profit of S$211.7 million for H1
14:02		Singapore Land posts 90% higher H1 net profit of S$211.7 million
14:02		Sea Q2 earnings up 10.6% at US$458.1 million as Shopee hits new highs
14:01		Rocket Lab CEO Won’t Take on Musk and Bezos in Broadband: ‘The Two Most Wealthiest People in the World Are Going After That’
14:01		EXCLUSIVE: Meta’s OpenAI Push Puts Pressure on Private AI Valuations
14:01		EXCLUSIVE: Renovorx Advances Its Targeted Pancreatic Cancer Therapy, Pivotal Data Expected in 2027
13:59		The Perils of Wall St.’s Race to Pour Billions More Into A.I.
13:59		Target To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Tuesday
13:58		How To Earn $500 A Month From Tapestry Stock Ahead Of Q4 Earnings
13:56		Apple Immersive Video: Nun auch Baseball auf der Vision Pro
13:51		Elon Musk's SpaceX Lands a New Asian Customer as Vietnam Steps Up Its Space Ambitions
13:50		MetaOptics H1 revenue grows by nearly six times; company on track to fill orders in H2
13:46		As Lumentum gears up for earnings, here’s a sign the optical trade is clawing back
13:40		Will Nvidia Split Its Stock Again in 2026?
13:39		Why Is Intel Stock Falling Tuesday?
13:36		Swiss Re: Katastrophenschäden sinken - doch die Risiken steigen
13:30		DoorDash Director Andy Fang Sells 15,000 Shares for $3.2 Million
13:29		Fortuna Mining buys Barrick, IAMGOLD Senegal project for $200M
13:27		Frasers Property to put hospitality portfolio revamp to shareholder vote on Aug 28
13:24		SpaceX Could Be Worth $14 Trillion? Billionaire Investor Ron Baron Has a Wild 10-Year Vision
13:23		China’s car sales extend slide as shift accelerates to overseas markets
13:19		Germany news: Some shipping stops as Rhine hits new lows
13:18		Nebius Just Made a Genius Move. Here's Why It Matters.
13:18		This fund manager tunes out AI hype to flag the infrastructure stocks to buy now. Think roads, water and telecom towers.
13:17		Prediction: You Won't Recognize Plug Power in 2028. Should You Buy the Hydrogen Stock Before It's Too Late?
13:12		Meta, TikTok, Google and Snap Just Lost a Major Court Battle— and Must Face More Than 3,000 Lawsuits Over Addictive Platforms Targeting Young Users
13:00		Intel investors are banking on a comeback — and then some

Erste Seite Zurück | ... | 2 | 3 | 4 | 5 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: American Drive Acquisition Company Registered a AgomAb Therapeutics urban-gro Focus Universal Titan Biotech

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 80% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	11.08.2026 19:31
Kaufwert:	EUR
	Hinzufügen Speichern

Eikon Therapeutics Aktie

WKN DE: A422F7 / ISIN: US2825641036

Eikon Therapeutics Times and Sales (NAS)

Analysen zu Eikon Therapeutics Inc Registered Shs

Weitere Meldungen